The publicly listed company Propanc Biopharma plans to acquire 100 million dollars in Ethereum
ChainCatcher news, biopharmaceutical company Propanc Biopharma (NASDAQ: PPCB) announced plans to acquire $100 million worth of Ethereum in the next 12 months.
The company stated that this move will enhance its corporate strategy in various areas including cryptocurrency investment, drug development, and asset acquisition.
ChainCatcher reminds readers to view blockchain rationally, enhance risk awareness, and be cautious of various virtual token issuances and speculations. All content on this site is solely market information or related party opinions, and does not constitute any form of investment advice. If you find sensitive information in the content, please click , and we will handle it promptly.
Related tags






